Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PedsVL study of sodium valproate + lamotrigine for pediatric drug-resistant epilepsy
jRCT1031240304Active, not recruiting
- Sponsor
- University of Tsukuba Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of valproic acid and lamotrigine in epilepsy, sponsored by University of Tsukuba Hospital. Primary endpoint: Percentage of seizure-free patients in the maintenance phase. Started Apr 2026; status: active, not recruiting.
02
Drugs
valproic acidlamotrigine
03
Conditions
epilepsy
Beyond the preview
Go deeper on jRCT1031240304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031240304.